Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Salix X Fragilis Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of Type I hypersensitivity to hybrid willow pollen. It belongs to the class of non-standardized pollen allergenic extracts and is administered via epicutaneous or subcutaneous routes.
Name
Salix X Fragilis Pollen
Raw Name
SALIX X FRAGILIS POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Salix X Fragilis Pollen
Salix X Fragilis Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of Type I hypersensitivity to hybrid willow pollen. It belongs to the class of non-standardized pollen allergenic extracts and is administered via epicutaneous or subcutaneous routes.
Detailed information about Salix X Fragilis Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Salix X Fragilis Pollen.
Salix X Fragilis Pollen, derived from the hybrid willow (a cross between Salix fragilis or Crack Willow and Salix alba or White Willow), is a biological substance used in the field of clinical allergology. It is categorized as a Non-Standardized Pollen Allergenic Extract [EPC]. Unlike standardized extracts, which have a potency measured in Bioequivalent Allergy Units (BAU), non-standardized extracts like Salix X Fragilis are typically prepared based on weight/volume (w/v) ratios or Protein Nitrogen Units (PNU). This extract is primarily utilized by healthcare providers for the diagnosis of allergic rhinitis (hay fever), allergic conjunctivitis, and seasonal asthma through skin testing. Additionally, it may be used in allergen immunotherapy (AIT), a process commonly known as 'allergy shots,' to induce immunological tolerance in patients with confirmed sensitivity to willow pollen.
According to the FDA-approved labeling for allergenic extracts, these products work by exposing the patient’s immune system to minute, controlled amounts of the offending allergen. Salix X Fragilis Pollen belongs to a class of drugs called allergenic extracts, which are unique because they serve both diagnostic and therapeutic purposes. The FDA has regulated these extracts for decades, with many non-standardized extracts remaining on the market based on historical use and expert consensus regarding their utility in identifying specific seasonal triggers. The Salix genus is particularly relevant in temperate climates where willow trees are prevalent and contribute to the spring 'pollen load,' often cross-reacting with other members of the Salicaceae family, such as poplars and aspens.
The mechanism of action for Salix X Fragilis Pollen depends on its application. In a diagnostic setting, such as a skin prick test (SPT), the extract is introduced into the epidermis. If the patient has pre-existing IgE (Immunoglobulin E) antibodies specific to Salix pollen, these antibodies—which are bound to the surface of mast cells in the skin—will cross-link with the introduced allergens. This cross-linking triggers mast cell degranulation, releasing histamine, leukotrienes, and prostaglandins. This physiological cascade results in the 'wheal and flare' reaction (a raised bump and surrounding redness), which is the hallmark of a positive diagnostic test.
In the context of immunotherapy, the mechanism is more complex and involves a shift in the patient's immune response. Regular, escalating subcutaneous injections of Salix X Fragilis Pollen aim to move the immune system away from a Th2-dominated response (which promotes IgE production and allergy) toward a Th1-dominated response. This process induces the production of 'blocking antibodies,' specifically IgG4 (Immunoglobulin G4). These IgG4 antibodies compete with IgE for the allergen binding sites, effectively preventing the allergic cascade. Furthermore, immunotherapy promotes the activity of T-regulatory (Treg) cells, which secrete anti-inflammatory cytokines like IL-10 and TGF-beta, further suppressing the allergic inflammation at the molecular level.
Traditional pharmacokinetic parameters (absorption, distribution, metabolism, and excretion) do not apply to Salix X Fragilis Pollen in the same way they do to small-molecule drugs. Because it is a complex mixture of proteins and glycoproteins, its 'kinetics' are better described in immunological terms.
Salix X Fragilis Pollen is indicated for:
This extract is available in several concentrations and preparations:
> Important: Only your healthcare provider can determine if Salix X Fragilis Pollen is right for your specific condition. Diagnosis and treatment should only be performed by a specialist trained in allergy and immunology.
Dosage for Salix X Fragilis Pollen is highly individualized and must be determined by an allergist based on the patient's sensitivity level. There is no 'standard' dose due to the non-standardized nature of the extract.
Salix X Fragilis Pollen is generally considered safe for use in children, though testing and therapy are rarely initiated in children under the age of 5 due to the difficulty of administration and the evolving nature of the pediatric immune system. The dosing logic for children is similar to adults—based on skin reactivity—but healthcare providers often use more conservative build-up schedules to minimize the risk of systemic reactions.
No dosage adjustments are required for patients with renal impairment, as the extract is not cleared by the kidneys in a manner that affects systemic toxicity.
No dosage adjustments are required for patients with hepatic impairment.
In elderly patients, the skin's reactivity to histamine and allergens may be reduced. Healthcare providers must interpret skin test results cautiously. Furthermore, the risk of systemic reactions to immunotherapy may be higher in older adults with underlying cardiovascular disease.
Salix X Fragilis Pollen is never self-administered. It must be administered by a healthcare professional in a clinical setting equipped to treat anaphylaxis.
In immunotherapy, if a dose is missed, the next dose may need to be reduced depending on how much time has passed.
An 'overdose' in the context of allergenic extracts occurs if a patient is given a concentration significantly higher than their current tolerance level. Signs of overdose include immediate systemic reactions such as generalized hives (urticaria), swelling of the throat (angioedema), wheezing, or a drop in blood pressure. Emergency treatment with epinephrine is required immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance, as this increases the risk of a reaction.
The most common side effects of Salix X Fragilis Pollen occur at the site of administration. These are expected immunological responses rather than 'toxic' side effects.
> Warning: Stop taking Salix X Fragilis Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects associated with Salix X Fragilis Pollen. Immunotherapy is designed to have long-term beneficial effects on the immune system. However, if a patient is improperly managed, repeated large local reactions could theoretically lead to minor subcutaneous scarring (fibrosis) at the injection sites over several years. There is no evidence that allergenic extracts increase the risk of autoimmune diseases or cancer.
Allergenic extracts, including Salix X Fragilis Pollen, carry significant risks. While not always formatted as a 'black box' on every single non-standardized label, the FDA requires prominent warnings regarding Anaphylaxis.
Summary of Warning Content:
Report any unusual symptoms or delayed reactions (occurring hours after the injection) to your healthcare provider immediately.
Salix X Fragilis Pollen is a potent biological substance. It is not a medication in the traditional sense but an 'immunomodulator.' The primary safety concern is the unpredictable nature of the immune system. A dose that was well-tolerated last week may cause a reaction this week if the patient's underlying 'allergic load' is higher (e.g., during peak willow pollination season or if the patient is currently ill).
No FDA black box warnings for Salix X Fragilis Pollen specifically in the same format as high-risk pharmaceuticals like antidepressants, but the 'General Warning' for all allergenic extracts serves an identical purpose. It emphasizes that anaphylaxis can occur even in patients who have previously tolerated the extract. It also notes that patients taking Beta-Blockers may be resistant to the effects of epinephrine, making a systemic reaction much harder to treat.
There are no standard laboratory tests (like blood counts or liver enzymes) required for Salix X Fragilis Pollen. Instead, monitoring is clinical:
Salix X Fragilis Pollen does not typically cause sedation. However, if a patient experiences a systemic reaction or a vasovagal response (fainting), their ability to drive will be impaired. It is generally recommended to wait until the 30-minute observation period is over and you feel completely normal before driving.
Alcohol consumption should be avoided on the day of an injection. Alcohol causes vasodilation (widening of blood vessels), which could theoretically increase the rate of allergen absorption and heighten the risk of a systemic reaction.
Immunotherapy can be stopped at any time, but stopping prematurely (before 3 years) usually results in the return of allergy symptoms. There is no 'withdrawal syndrome' associated with stopping Salix X Fragilis Pollen, as it is not a physically addictive substance.
> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Salix X Fragilis Pollen.
There are no direct food interactions with Salix X Fragilis Pollen. However, patients with 'Pollen-Food Allergy Syndrome' (Oral Allergy Syndrome) may find that their sensitivity to certain raw fruits (like apples or cherries) increases during the period they are receiving willow pollen injections, as the immune system is in a heightened state of awareness.
For each major interaction, the mechanism is usually pharmacodynamic (affecting the body's response to the drug or the emergency treatment for the drug) rather than pharmacokinetic (affecting the drug's levels in the blood).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any heart or blood pressure medications.
Salix X Fragilis Pollen must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the allergist:
Patients allergic to Salix X Fragilis Pollen often show cross-sensitivity to:
> Important: Your healthcare provider will evaluate your complete medical history, including your heart and lung health, before prescribing Salix X Fragilis Pollen.
FDA Pregnancy Category: C.
There are no adequate and well-controlled studies of Salix X Fragilis Pollen in pregnant women. The primary concern is not the extract itself (which does not cross the placenta in significant amounts) but the risk of maternal anaphylaxis. Anaphylaxis can cause maternal hypotension, leading to fetal hypoxia (lack of oxygen) and potential fetal distress or death.
It is not known whether Salix X Fragilis Pollen components are excreted in human milk. However, because the allergens are proteins that are degraded at the injection site and in the lymphatics, it is highly unlikely that intact allergens would reach the breast milk or affect the nursing infant. Breastfeeding is generally not considered a contraindication for continuing immunotherapy.
As discussed, Salix X Fragilis Pollen is used for diagnosis and treatment in children, typically those over age 5. The efficacy of immunotherapy in children is well-documented, often preventing the 'allergic march' (the progression from allergic rhinitis to asthma). Special care must be taken to ensure the child can sit still for the 30-minute observation period and can describe symptoms like an 'itchy throat' or 'funny feeling' that might signal a reaction.
Elderly patients (over age 65) may have a higher prevalence of co-morbidities like coronary artery disease or COPD, which increases the risk of complications if a systemic reaction occurs. Furthermore, skin reactivity decreases with age, which can lead to false-negative skin tests. Allergists often use lower starting doses and slower build-up schedules for geriatric patients.
Renal impairment does not alter the immunological processing of pollen extracts. No specific dose adjustments are required, though the patient's overall health and ability to tolerate emergency medications should be considered.
Hepatic impairment does not affect the safety or efficacy of Salix X Fragilis Pollen. Proteins are metabolized by general cellular proteases rather than the hepatic CYP450 system.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Salix X Fragilis Pollen acts as an immunomodulating agent. At the molecular level, the extract contains various proteins (allergens) that are recognized by the immune system.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Epicutaneous) |
| Protein Binding | N/A (Processed by APCs) |
| Half-life | Localized proteins degraded within hours/days |
| Tmax | 15-30 minutes for local immunological peak |
| Metabolism | Proteolytic degradation in tissues |
| Excretion | Not renally excreted as intact drug |
Salix X Fragilis Pollen is a member of the Allergenic Extracts therapeutic class. It shares this class with other tree pollens (e.g., Oak, Birch), grass pollens (e.g., Timothy, Bermuda), and weed pollens (e.g., Ragweed). It is specifically 'Non-Standardized,' meaning its potency is not compared to a national standard reference serum in a laboratory bioassay.
Common questions about Salix X Fragilis Pollen
Salix X Fragilis Pollen is primarily used by allergy specialists to diagnose and treat allergies to willow tree pollen. In the diagnostic phase, it is used in skin prick tests to see if a patient develops a 'wheal and flare' reaction, confirming they are allergic to this specific hybrid willow. In the treatment phase, it is used in allergen immunotherapy, commonly known as allergy shots. This involves giving the patient gradually increasing amounts of the pollen to help their immune system build up a tolerance. Over time, this can significantly reduce symptoms like sneezing, itchy eyes, and nasal congestion during the spring. It is only used for patients whose symptoms are not well-controlled by standard medications.
The most common side effects are localized to the area where the extract was applied or injected. During a skin test, most patients will experience an itchy, red bump that looks like a mosquito bite, which usually disappears within an hour or two. For those receiving immunotherapy injections, redness, itching, and swelling at the injection site are very common and can last for a day. Some patients may also feel slightly more tired than usual or experience a temporary increase in their typical allergy symptoms. These reactions are generally mild and are a sign that the immune system is responding to the allergen. However, any large swelling should be reported to the doctor before the next dose.
It is generally advised to avoid alcohol on the day you receive a Salix X Fragilis Pollen injection. Alcohol can cause your blood vessels to dilate (widen), which might increase the speed at which the pollen extract is absorbed into your bloodstream. This faster absorption could potentially increase the risk of a systemic or serious allergic reaction. Additionally, alcohol can sometimes mask the early symptoms of an allergic reaction, such as feeling lightheaded or flushed. To ensure the highest level of safety during your treatment, most allergists recommend waiting at least 24 hours after an injection before consuming alcohol. Always follow the specific instructions provided by your allergy clinic.
The safety of Salix X Fragilis Pollen during pregnancy is a complex issue that requires a discussion with your doctor. Most allergists will not start a new course of immunotherapy while a patient is pregnant because of the risk of anaphylaxis, which could deprive the baby of oxygen. However, if a woman is already on a stable 'maintenance' dose and has been tolerating it well before becoming pregnant, the treatment is often continued. The dose is usually kept the same or even reduced slightly to minimize any risk. There is no evidence that the pollen extract itself causes birth defects. The primary goal is to avoid any severe allergic reactions in the mother during the pregnancy.
If you are using Salix X Fragilis Pollen for diagnostic testing, the results are almost immediate, appearing within 15 to 20 minutes of the skin prick. However, if you are undergoing immunotherapy (allergy shots), the process is much slower. Most patients do not notice a significant improvement in their willow allergy symptoms until they reach their 'maintenance dose,' which typically takes 3 to 6 months of weekly injections. Full clinical benefits are usually seen after the first full allergy season at the maintenance level. For the best long-term results, the treatment is usually continued for 3 to 5 years. This long duration is necessary to 'retrain' the immune system permanently.
Yes, you can stop receiving Salix X Fragilis Pollen injections at any time without experiencing physical withdrawal symptoms. Unlike some medications that affect the nervous system or hormones, allergenic extracts do not cause dependency. However, if you stop the treatment before completing the recommended 3 to 5-year course, your allergy symptoms are likely to return over time. The 'tolerance' built up by the immune system may not be permanent if the treatment is cut short. If you need to stop due to pregnancy, illness, or financial reasons, you should discuss a plan with your allergist. They can advise you on how to manage your symptoms using other medications.
If you miss an immunotherapy appointment for Salix X Fragilis Pollen, you should contact your allergist's office as soon as possible to reschedule. Missing a dose can affect your safety because your immune system's tolerance may drop slightly if the interval between shots is too long. If you are only a few days late, your doctor may give you the usual dose. However, if you have missed several weeks, the doctor will likely need to reduce the dose for your next shot to prevent a reaction. If a significant amount of time has passed, you might even need to restart the build-up phase from a lower concentration. Never try to 'double up' on doses to make up for a missed one.
There is no scientific evidence to suggest that Salix X Fragilis Pollen causes weight gain. The extract consists of small amounts of naturally occurring proteins and does not contain calories, hormones, or metabolic-altering chemicals that would lead to an increase in body fat. If you notice weight changes while undergoing immunotherapy, it is likely due to other factors, such as lifestyle changes, other medications (like oral steroids sometimes used for severe allergies), or unrelated medical conditions. If you have concerns about your weight, you should discuss them with your primary care physician. Immunotherapy is focused solely on the immune system's response to allergens.
Salix X Fragilis Pollen can be taken alongside most common medications, but there are some very important exceptions. You must tell your doctor if you are taking beta-blockers (often used for blood pressure or heart issues), as these can make it dangerous to treat an allergic reaction if one occurs. You should also mention if you are taking MAO inhibitors or ACE inhibitors. For diagnostic skin testing, you must stop taking antihistamines and certain antidepressants for several days beforehand, as they can block the skin's reaction and lead to incorrect test results. Most other routine medications, such as those for cholesterol or diabetes, do not interact with pollen extracts.
The concept of 'generic' vs. 'brand name' works differently for allergenic extracts like Salix X Fragilis Pollen. These are biological products rather than simple chemical drugs. Different manufacturers may produce their own versions of Salix X Fragilis Pollen extract, but they are not considered interchangeable because they are 'non-standardized.' This means the exact protein concentration and potency can vary between different companies. If you start treatment with an extract from one manufacturer, your allergist will generally try to keep you on that same manufacturer's product throughout your therapy. If a switch is necessary, the doctor will often reduce the dose significantly to ensure your safety during the transition.